ICL Group reported Q1 2026 earnings this morning with a beat on both lines. Adj. EPS came in at $0.11 against a $0.10 estimate. Revenue hit $2.023B. Management raised its full-year 2026 outlook, citing surging potash sales. The stock is up 14% on the week — but the rally itself is now the story, not the earnings beat.
The stock ran hard into the print. ICL gained roughly 19% between late April and Tuesday's close, compressing the post-results pop and prompting at least one analyst to downgrade to Hold this morning on a "fully valued" argument. Seeking Alpha's write-up, published within two hours of the release, framed the earnings beat as having already been priced in. At $6.38, trailing P/E has re-rated to 15.9x from around 13.7x over the past 30 days. EV/EBITDA has compressed in the other direction — down to 6.76x — as enterprise value has tracked the run-up in equity while EBITDA estimates held steady. The value score in ORTEX's factor framework has already begun fading, dropping from 70 to 65.8 over the past fortnight as momentum absorbed the valuation cushion that made the stock interesting in March.
The short interest picture does not suggest an aggressive bear case, but it has been quietly building alongside the rally. SI has climbed from 0.43% of the free float in late April to 0.54% as of Tuesday — a move that mirrors the 16% jump in shares short over the week. That remains a very low absolute level, and with the borrow market running at around 6.5% cost-to-borrow, new shorts are not entering cheaply. Borrow availability has tightened over the past fortnight to its highest point in 52 weeks, which means demand for borrows has grown even as the stock rallied. The ORTEX short score has climbed from 36.7 to 40.5 over the past two weeks — a steady drift higher, not a spike. Options confirm the lack of real conviction on either side: the put/call ratio is flat near 0.046, effectively in line with its 20-day average. Calls dominate the open interest by a wide margin.
The factor profile tells a nuanced story. Growth ranks in the 64th percentile — solid, driven by forward EPS expectations that rank in the 75th percentile for year-on-year increase. The dividend score is strong at the 83rd percentile; ICL announced a dividend distribution this morning alongside results. Momentum has been rising sharply, now approaching the 49th percentile from the 38th just a month ago — reflecting the price action rather than any fundamental upgrade. What has faded is value. The quality score has also softened from 50 to 42 over the same period, a gradual deterioration that may reflect margin pressures showing up in the most recent quarterly data.
Ownership is dominated by Israel Corporation, which controls 43.9% of shares and has not changed its position. Israeli institutional names — Migdal, Altshuler Shaham, Meitav — collectively hold another 11%+ and have been modest net buyers in recent filings. Norges Bank Investment Management added over 20 million shares as of December 2025, a notable sovereign fund move that adds a credible long-side anchor. The insider record on the NYSE listing is thin; the only trade in the trailing 90 days was a small controller sale worth around $14,000 in February. Peer MOS — Mosaic — missed its own Q1 estimates last week and fell roughly 3.7% on the week, which likely provided some tailwind for ICL's relative outperformance heading into today's print.
With the earnings catalyst now behind it and the "fully valued" narrative starting to circulate, the next question for ICL is whether the raised 2026 guidance holds through the summer, and whether potash prices can sustain the volume momentum management cited this morning.
See the live data behind this article on ORTEX.
Open ICL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
